Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Würzburg rekrutiert ersten Patienten für Studie zum Herz- und Nierenschutz

The Universitätsklinikum Würzburg, Germany screened their first EMPA-KIDNEY participant on 14th February 2019.

You can read thier press release (in German) on the Universitätsklinikum Würzburg website.